BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tan Y, Wang M, Zhang Y, Ge S, Zhong F, Xia G, Sun C. Tumor-Associated Macrophages: A Potential Target for Cancer Therapy. Front Oncol 2021;11:693517. [PMID: 34178692 DOI: 10.3389/fonc.2021.693517] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 16.0] [Reference Citation Analysis]
Number Citing Articles
1 Adams R, Osborn G, Mukhia B, Laddach R, Willsmore Z, Chenoweth A, Geh JLC, Mackenzie Ross AD, Healy C, Barber L, Tsoka S, Sanz-moreno V, Lacy KE, Karagiannis SN. Influencing tumor-associated macrophages in malignant melanoma with monoclonal antibodies. OncoImmunology 2022;11:2127284. [DOI: 10.1080/2162402x.2022.2127284] [Reference Citation Analysis]
2 Kang Z, Li S, Lin Y, Li Y, Mao Y, Zhang J, Lei T, Wang H, Su Y, Yang Y, Qiu J, Li W. A Phase I Dose-Escalation Study of SYHA1813, a VEGFRs and CSF1R Inhibitor, in Patients with Recurrent High-Grade Gliomas or Advanced Solid Tumors.. [DOI: 10.21203/rs.3.rs-2258310/v1] [Reference Citation Analysis]
3 Parayath NN, Gandham SK, Amiji MM. Tumor-targeted miRNA nanomedicine for overcoming challenges in immunity and therapeutic resistance. Nanomedicine (Lond) 2022. [PMID: 36255330 DOI: 10.2217/nnm-2022-0130] [Reference Citation Analysis]
4 Pan P, Wu T, Tsai H, Cho I, Tseng H, Lin T, Nan F, Wu Y. Acid external and internal environment exchange the Oreochromis niloticus tissue immune gene expression compared to the mouse macrophage polarization model. Front Immunol 2022;13:1012078. [DOI: 10.3389/fimmu.2022.1012078] [Reference Citation Analysis]
5 Su P, Jiang L, Zhang Y, Yu T, Kang W, Liu Y, Yu J. Crosstalk between tumor-associated macrophages and tumor cells promotes chemoresistance via CXCL5/PI3K/AKT/mTOR pathway in gastric cancer. Cancer Cell Int 2022;22:290. [PMID: 36151545 DOI: 10.1186/s12935-022-02717-5] [Reference Citation Analysis]
6 Suzuki E, Masaka N, Urabe T, Sasaki M, Hasumi K. Direct cell-cell interaction regulates division of stem cells from PC-3 human prostate cancer cell line. Biochem Biophys Res Commun 2022;631:25-31. [PMID: 36162326 DOI: 10.1016/j.bbrc.2022.09.004] [Reference Citation Analysis]
7 Chen S, Qian S, Zhang L, Pan X, Qu F, Yu Y, Gu Z, Cui X, Shen H. Tumor-associated macrophages promote migration and invasion via modulating IL-6/STAT3 signaling in renal cell carcinoma. Int Immunopharmacol 2022;111:109139. [PMID: 35964405 DOI: 10.1016/j.intimp.2022.109139] [Reference Citation Analysis]
8 Aramini B, Masciale V, Samarelli AV, Dubini A, Gaudio M, Stella F, Morandi U, Dominici M, De Biasi S, Gibellini L, Cossarizza A. Phenotypic, functional, and metabolic heterogeneity of immune cells infiltrating non–small cell lung cancer. Front Immunol 2022;13:959114. [DOI: 10.3389/fimmu.2022.959114] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Liu S, Tang W, Cao J, Shang M, Sun H, Gong J, Hu B. A Comprehensive Analysis of HAVCR1 as a Prognostic and Diagnostic Marker for Pan-Cancer. Front Genet 2022;13:904114. [PMID: 35754803 DOI: 10.3389/fgene.2022.904114] [Reference Citation Analysis]
10 Jorquera-cordero C, Lara P, Cruz LJ, Schomann T, van Hofslot A, de Carvalho TG, Guedes PMDM, Creemers L, Koning RI, Chan AB, de Araujo Junior RF. Extracellular Vesicles from M1-Polarized Macrophages Combined with Hyaluronic Acid and a β-Blocker Potentiate Doxorubicin’s Antitumor Activity by Downregulating Tumor-Associated Macrophages in Breast Cancer. Pharmaceutics 2022;14:1068. [DOI: 10.3390/pharmaceutics14051068] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
11 Andrea AE, Chiron A, Mallah S, Bessoles S, Sarrabayrouse G, Hacein-Bey-Abina S. Advances in CAR-T Cell Genetic Engineering Strategies to Overcome Hurdles in Solid Tumors Treatment. Front Immunol 2022;13:830292. [PMID: 35211124 DOI: 10.3389/fimmu.2022.830292] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
12 Qiu X, Zhao T, Luo R, Qiu R, Li Z. Tumor-Associated Macrophages: Key Players in Triple-Negative Breast Cancer. Front Oncol 2022;12:772615. [DOI: 10.3389/fonc.2022.772615] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
13 Zhang S, Wang H, Liu Y, Tao T, Zeng Z, Zhou Y, Wang M. Nocardia rubra cell-wall skeleton influences the development of cervical carcinoma by promoting the antitumor effect of macrophages and dendritic cells. Cancer Med 2022. [PMID: 34994088 DOI: 10.1002/cam4.4526] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Chabeli MS, Wang X, Yinghao L, Chen C, Yang C, Shou Y, Wang S, Chen K. Similarities between wound re-epithelialization and Metastasis in ESCC and the crucial involvement of macrophages: A review. Cancer Treatment and Research Communications 2022;32:100621. [DOI: 10.1016/j.ctarc.2022.100621] [Reference Citation Analysis]
15 Reale A, Calistri A, Altomonte J. Giving Oncolytic Viruses a Free Ride: Carrier Cells for Oncolytic Virotherapy. Pharmaceutics 2021;13:2192. [PMID: 34959474 DOI: 10.3390/pharmaceutics13122192] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Xie Y, Chen Z, Zhong Q, Zheng Z, Chen Y, Shangguan W, Zhang Y, Yang J, Zhu D, Xie W. M2 macrophages secrete CXCL13 to promote renal cell carcinoma migration, invasion, and EMT. Cancer Cell Int 2021;21. [DOI: 10.1186/s12935-021-02381-1] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 7.0] [Reference Citation Analysis]
17 Bouchard A, Sikner H, Baverel V, Garnier AR, Monterrat M, Moreau M, Limagne E, Garrido C, Kohli E, Collin B, Bellaye PS. The GRP94 Inhibitor PU-WS13 Decreases M2-like Macrophages in Murine TNBC Tumors: A Pharmaco-Imaging Study with 99mTc-Tilmanocept SPECT. Cells 2021;10:3393. [PMID: 34943901 DOI: 10.3390/cells10123393] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
18 Fowler D, Nattress C, Navarrete AS, Barisa M, Fisher J. Payload Delivery: Engineering Immune Cells to Disrupt the Tumour Microenvironment. Cancers (Basel) 2021;13:6000. [PMID: 34885108 DOI: 10.3390/cancers13236000] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
19 Petty AJ, Owen DH, Yang Y, Huang X. Targeting Tumor-Associated Macrophages in Cancer Immunotherapy. Cancers (Basel) 2021;13:5318. [PMID: 34771482 DOI: 10.3390/cancers13215318] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]